Lawrence Bernard Gozlan
CIK: 0002127737
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATHE
ALTERITY THERAPEUTICS LTD
Director
Discretionary Trading P&L
Holdings
About Gozlan Lawrence Bernard
Gozlan Lawrence Bernard (SEC CIK 0002127737) files insider reports with the SEC as Director of ALTERITY THERAPEUTICS LTD (ATHE).
Signal8 holds 2 ownership filings by Gozlan Lawrence Bernard (1 Form 3, 1 Form 4), filed between Apr 10, 2026 and Jun 23, 2026. Those filings report 1 transaction, the latest on Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gozlan Lawrence Bernard's filings is in MELBOURNE.
Recent filings by Gozlan Lawrence Bernard
- Jun 15, 2026: Grant or award of ATHE derivative securities (Form 4, code A).
Other insiders filing for ALTERITY THERAPEUTICS LTD (ATHE)
- Marks Peter Ashley, Director
- Stamler David Allen, Chief Executive Officer
- Babarczy Julian Michael, Director
- Cunningham Ann Michelle, Director
- Macnish Niven Abby Sarah, Chief Financial Officer